Gene expression and chromosomal location for susceptibility to Sjögren's syndrome

Journal of Autoimmunity

Volumn 33, Issue 2, 2009, Pages 99-108

  Pérez, Paola ^a   Anaya, Juan Manuel ^b   Aguilera, Sergio ^c   Urzúa, Ulises ^a   Munroe, David ^d   Molina, Claudio ^e   Hermoso, Marcela A ^a   Cherry, James Michael ^d   Alliende, Cecilia ^a   Olea, Nancy ^a   Ruiz Narváez, Edward ^f   González, María Julieta ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c UNIVERSIDAD ANDRÉS BELLO   (Chile)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSIDAD MAYOR   (Chile)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Apoptosis; cDNA microarray; Epithelial cells; Genome wide association study; Interferon; Sj gren's syndrome

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; INTERFERON; RNA;

ADULT; AGED; APOPTOSIS; ARTICLE; CHROMOSOMAL LOCALIZATION; CONTROLLED STUDY; DNA MICROARRAY; EPITHELIUM CELL; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCUS; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; SALIVARY GLAND; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME;

ADULT; AGED; ALLELES; CHROMOSOMES, HUMAN; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 68249087935     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.05.001     Document Type: Article

References (56)

1. Anaya J.-M., Vega P., Correa P.A., Kwon Y.J., Brito M., Alliende C., et al. Síndrome de Sjögren. In: Anaya J.M., Shoenfeld Y., Correa P.A., García-Carrasco M., and Cervera R. (Eds). Autoinmunidad y Enfermedad Autoinmune (2005), Corporación para Investigaciones Biológicas, Medellin 295-315
2. Humphreys-Beher M.G., Peck A.B., Dang H., and Talal N. The role of apoptosis in the initiation of theautoimmune response in Sjogren's syndrome. Clin Exp Immunol 116 (1999) 383-387
3. Mitsias D.I., Kapsogeorgou E.K., and Moutsopoulos H.M. The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: lessons from Sjogren's syndrome (autoimmune epithelitis). Lupus 15 (2006) 255-261
4. Perez P., Goicovich E., Alliende C., Aguilera S., Leyton C., Molina C., et al. Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum 43 (2000) 2807-2817
5. Perez P., Kwon Y.J., Alliende C., Leyton L., Aguilera S., Molina C., et al. Increased acinar damage of salivary glands of patients with Sjogren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios. Arthritis Rheum 52 (2005) 2751-2760
6. Goicovich E., Molina C., Perez P., Aguilera S., Fernandez J., Olea N., et al. Enhanced degradation of proteins of the basal lamina and stroma by matrix metalloproteinases from the salivary glands of Sjogren's syndrome patients: correlation with reduced structural integrity of acini and ducts. Arthritis Rheum 48 (2003) 2573-2584
7. Anaya J.M., Tobon G.J., Vega P., and Castiblanco J. Autoimmune disease aggregation in families with primary Sjogren's syndrome. J Rheumatol 33 (2006) 2227-2234
8. Foster H., Stephenson A., Walker D., Cavanagh G., Kelly C., and Griffiths I. Linkage studies of HLA and primary Sjogren's syndrome in multicase families. Arthritis Rheum 36 (1993) 473-484
9. Anaya J.M., Delgado-Vega A.M., and Castiblanco J. Genetic basis of Sjogren's syndrome. How strong is the evidence?. Clin Dev Immunol 13 (2006) 209-222
10. Killedar S.J., Eckenrode S.E., McIndoe R.A., She J.X., Nguyen C.Q., Peck A.B., et al. Early pathogenic events associated with Sjogren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis. Lab Invest 86 (2006) 1243-1260
11. Hjelmervik T.O., Petersen K., Jonassen I., Jonsson R., and Bolstad A.I. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects. Arthritis Rheum 52 (2005) 1534-1544
12. Gottenberg J.E., Cagnard N., Lucchesi C., Letourneur F., Mistou S., Lazure T., et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc Natl Acad Sci U S A 103 (2006) 2770-2775
13. Daniels T.E. Labial salivary gland biopsy in Sjogren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 27 (1984) 147-156
14. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61 (2002) 554-558
15. Bravo M.L., Valenzuela C.Y., and Arcos-Burgos O.M. Polymorphisms and phyletic relationships of the Paisa community from Antioquia (Colombia). Gene Geogr 10 (1996) 11-17
16. Arcos-Burgos M., and Muenke M. Genetics of population isolates. Clin Genet 61 (2002) 233-247
17. Herrero J., Vaquerizas J.M., Al-Shahrour F., Conde L., Mateos A., Diaz-Uriarte J.S., et al. New challenges in gene expression data analysis and the extended GEPAS. Nucleic Acids Res 32 (2004) W485-W491
18. Herrero J., Al-Shahrour F., Diaz-Uriarte R., Mateos A., Vaquerizas J.M., Santoyo J., et al. GEPAS: a web-based resource for microarray gene expression data analysis. Nucleic Acids Res 31 (2003) 3461-3467
19. Pritchard J.K., Stephens M., and Donnelly P. Inference of population structure using multilocus genotype data. Genetics 155 (2000) 945-959
20. Pritchard J.K., Stephens M., Rosenberg N.A., and Donnelly P. Association mapping in structured populations. Am J Hum Genet 67 (2000) 170-181
21. Kawasaki S., Kawamoto S., Yokoi N., Connon C., Minesaki Y., Kinoshita S., et al. Up-regulated gene expression in the conjunctival epithelium of patients with Sjogren's syndrome. Exp Eye Res 77 (2003) 17-26
22. Ogawa N., Ping L., Zhenjun L., Takada Y., and Sugai S. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjogren's syndrome. Arthritis Rheum 46 (2002) 2730-2741
23. Eliasson L., Almstahl A., Lingstrom P., Wikstrom M., and Carlen A. Minor gland saliva flow rate and proteins in subjects with hyposalivation due to Sjogren's syndrome and radiation therapy. Arch Oral Biol 50 (2005) 293-299
24. Haghighat N., and al-Hashimi I. The status of lactoferrin and total iron binding capacity of human parotid saliva in Sjogren's syndrome. Clin Exp Rheumatol 21 (2003) 485-488
25. Hansen A., Reiter K., Ziprian T., Jacobi A., Hoffmann A., Gosemann M., et al. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjogren's syndrome. Arthritis Rheum 52 (2005) 2109-2119
26. Ohyama Y., Nakamura S., Matsuzaki G., Shinohara M., Hiroki A., Oka M., et al. T-cell receptor V alpha and V beta gene use by infiltrating T cells in labial glands of patients with Sjogren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79 (1995) 730-737
27. Nakken B., Jonsson R., Brokstad K.A., Omholt K., Nerland A.H., Haga H.J., et al. Associations of MHC class II alleles in Norwegian primary Sjogren's syndrome patients: implications for development of autoantibodies to the Ro52 autoantigen. Scand J Immunol 54 (2001) 428-433
28. Manganelli P., and Fietta P. Apoptosis and Sjogren syndrome. Semin Arthritis Rheum 33 (2003) 49-65
29. Loiseau P., Lepage V., Djelal F., Busson M., Tamouza R., Raffoux C., et al. HLA class I and class II are both associated with the genetic predisposition to primary Sjogren syndrome. Hum Immunol 62 (2001) 725-731
30. Azuma T., Takei M., Yoshikawa T., Nagasugi Y., Kato M., Otsuka M., et al. Identification of candidate genes for Sjogren's syndrome using MRL/lpr mouse model of Sjogren's syndrome and cDNA microarray analysis. Immunol Lett 81 (2002) 171-176
31. Fei H.M., Kang H., Scharf S., Erlich H., Peebles C., and Fox R. Specific HLA-DQA and HLA-DRB1 alleles confer susceptibility to Sjogren's syndrome and autoantibody production. J Clin Lab Anal 5 (1991) 382-391
32. Kay R.A., Hutchings C.J., and Ollier W.E. A subset of Sjogren's syndrome associates with the TCRBV13S2 locus but not the TCRBV2S1 locus. Hum Immunol 42 (1995) 328-330
33. Emamian E.S., Leon J.M., Lessard C.J., Grandits M., Baechler M.C., Gaffney P.M., et al. Peripheral blood gene expression profiling in Sjögren's syndrome. Genes Immun (2009 Apr 30) [Epub ahead of print]
34. Wildenberg M.E., van Helden-Meeuwsen C.G., van de Merwe J.P., Drexhage H.A., and Versnel M.A. Systemic increase in type I interferon activity in Sjögren's syndrome: a putative role for plasmacytoid dendritic cells. Eur J Immunol 38 (2008) 2024-2033
35. Molina C., Alliende C., Aguilera S., Kwon Y.J., Leyton L., Martinez B., et al. Basal lamina disorganisation of the acini and ducts of labial salivary glands from patients with Sjogren's syndrome: association with mononuclear cell infiltration. Ann Rheum Dis 65 (2006) 178-183
36. Philchenkov A. Caspases: potential targets for regulating cell death. J Cell Mol Med 8 (2004) 432-444
37. Rothwarf D.M., and Karin M. The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE (1999) 1999:RE1
38. Fay M.J., Longo K.A., Karathanasis G.A., Shope D.M., Mandernach C.J., Leong J.R., et al. Analysis of CUL-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissues. Mol Cancer 2 (2003) 40
39. Martin A.G., San-Antonio B., and Fresno M. Regulation of nuclear factor kappa B transactivation. Implication of phosphatidylinositol 3-kinase and protein kinase C zeta in c-Rel activation by tumor necrosis factor alpha. J Biol Chem 276 (2001) 15840-15849
40. De Laurenzi V., and Melino G. Apoptosis. The little devil of death. Nature 406 (2000) 135-136
41. Strasser A. The role of BH3-only proteins in the immune system. Nat Rev Immunol 5 (2005) 189-200
42. Sisto M., Lisi S., Castellana D., Scagliusi P., D'Amore M., Caprio S., et al. Autoantibodies from Sjogren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253. J Autoimmun 27 (2006) 38-49
43. Lauricella M., Emanuele S., D'Anneo A., Calvaruso G., Vassallo B., Carlisi D., et al. JNK and AP-1 mediate apoptosis induced by bortezomib in HepG2 cells via FasL/caspase-8 and mitochondria-dependent pathways. Apoptosis 11 (2006) 607-625
44. Kwon Y.J., Perez P., Aguilera S., Molina C., Leyton L., Alliende C., et al. Involvement of specific laminins and nidogens in the active remodeling of the basal lamina of labial salivary glands from patients with Sjogren's syndrome. Arthritis Rheum 54 (2006) 3465-3475
45. Alberts B., Johnson A., Lewis J., Raff M., Roberts K., and Walter E. Internal Organization of the cell. In: GS T. (Ed). Molecular biology of the cell (2007), Taylor & Francis Group
46. Oliveira S.S., and Morgado-Diaz J.A. Claudins: multifunctional players in epithelial tight junctions and their role in cancer. Cell Mol Life Sci 64 (2007) 17-28
47. Fievet B., Louvard D., and Arpin M. ERM proteins in epithelial cell organization and functions. Biochim Biophys Acta 1773 (2007) 653-660
48. Takaoka A., and Yanai H. Interferon signalling network in innate defence. Cell Microbiol 8 (2006) 907-922
49. Zhang L., and Pagano J.S. Structure and function of IRF-7. J Interferon Cytokine Res 22 (2002) 95-101
50. Bave U., Nordmark G., Lovgren T., Ronnelid J., Cajander S., Eloranta M.L., et al. Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum 52 (2005) 1185-1195
51. Vanbervliet B., Bendriss-Vermare N., Massacrier C., Homey B., de Bouteiller O., Briere F., et al. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J Exp Med 198 (2003) 823-830
52. Arumugam T.V., Okun E., Tang S.C., Thundyil J., Taylor S.M., and Woodruff T.M. Toll-Like receptors in Ischemia-Reperfusion Injury. Shock (2008 Nov 11) [Epub ahead of print]
53. Liang J., Wang J., Azfer A., Song W., Tromp G., Kolattukudy P.E., et al. A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages. J Biol Chem 283 (2008) 6337-6346
54. Wang H., Walsh S.T., and Parthun M.R. Expanded binding specificity of the human histone chaperone NASP. Nucleic Acids Res 36 (2008) 5763-5772
55. Zhai D., Jin C., Huang Z., Satterthwait A.C., and Reed J.C. Differential regulation of Bax and Bak by anti-apoptotic Bcl-2 family proteins Bcl-B and Mcl-1. J Biol Chem 283 (2008) 9580-9586
56. Delgado-Vega A.M., Castiblanco J., Gómez L.M., Diaz-Gallo L.M., Rojas-Villarraga A., and Anaya J.M. BCL2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women. Ann Rheum Dis (2009 Mar 11) [Epub ahead of print]